GlassScriptPhysician profile
Kalyan Kalava
NPI 1881870400
$2,561.36
in general payments reported to CMS, 2019-2025
16 companies · $65.80 in 2025
The $65.80 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,175 · 2020: $138 · 2021: $286 · 2022: $222 · 2023: $353 · 2024: $321 · 2025: $65.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,368.48 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Scilex Pharmaceuticals INC. | $263.38 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $175.53 | 2019-2021 | |
| Pfizer INC. | $144.80 | 2019 | |
| Curonix LLC | $135.18 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.39 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.82 | 2019 | |
| Tersera Therapeutics LLC | $50.06 | 2019 | |
| Stimwave Technologies Incorporated | $41.66 | 2019 | |
| Shionogi INC | $40.61 | 2019 | |
| Assertio Therapeutics, INC. | $36.34 | 2019 | |
| Ziehm-Orthoscan, INC. | $30.22 | 2019 | |
| Kaleo, INC. | $26.11 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.06 | 2019 | |
| Medtronic USA, INC. | $16.67 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalyan Kalava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.